These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28581252)

  • 1. NAFLD in clinical practice: Can simple blood and anthropometric markers be used to detect change in liver fat measured by
    Keating SE; Parker HM; Hickman IJ; Gomersall SR; Wallen MP; Coombes JS; Macdonald GA; George J; Johnson NA
    Liver Int; 2017 Dec; 37(12):1907-1915. PubMed ID: 28581252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver Fat Scores Moderately Reflect Interventional Changes in Liver Fat Content by a Low-Fat Diet but Not by a Low-Carb Diet.
    Kabisch S; Bäther S; Dambeck U; Kemper M; Gerbracht C; Honsek C; Sachno A; Pfeiffer AFH
    Nutrients; 2018 Jan; 10(2):. PubMed ID: 29385034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease.
    Vongsuvanh R; George J; McLeod D; van der Poorten D
    J Hepatol; 2012 Aug; 57(2):392-8. PubMed ID: 22521350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes.
    Sviklāne L; Olmane E; Dzērve Z; Kupčs K; Pīrāgs V; Sokolovska J
    J Gastroenterol Hepatol; 2018 Jan; 33(1):270-276. PubMed ID: 28464337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome.
    Vassilatou E; Lafoyianni S; Vassiliadi DA; Ioannidis D; Paschou SA; Mizamtsidi M; Panagou M; Vryonidou A
    Maturitas; 2018 Oct; 116():1-7. PubMed ID: 30244768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals.
    Cuthbertson DJ; Weickert MO; Lythgoe D; Sprung VS; Dobson R; Shoajee-Moradie F; Umpleby M; Pfeiffer AF; Thomas EL; Bell JD; Jones H; Kemp GJ
    Eur J Endocrinol; 2014 Nov; 171(5):561-9. PubMed ID: 25298375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the Omega-3 Index in predicting non-alcoholic fatty liver disease in overweight and obese adults: a pilot study.
    Parker HM; O'Connor HT; Keating SE; Cohn JS; Garg ML; Caterson ID; George J; Johnson NA
    Br J Nutr; 2015 Sep; 114(5):780-7. PubMed ID: 26202539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An extended fatty liver index to predict non-alcoholic fatty liver disease.
    Kantartzis K; Rettig I; Staiger H; Machann J; Schick F; Scheja L; Gastaldelli A; Bugianesi E; Peter A; Schulze MB; Fritsche A; Häring HU; Stefan N
    Diabetes Metab; 2017 Jun; 43(3):229-239. PubMed ID: 28089502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome.
    Chen LD; Huang JF; Chen QS; Lin GF; Zeng HX; Lin XF; Lin XJ; Lin L; Lin QC
    Chin Med J (Engl); 2019 Nov; 132(22):2670-2676. PubMed ID: 31765354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound hepatic/renal ratio and hepatic attenuation rate for quantifying liver fat content.
    Zhang B; Ding F; Chen T; Xia LH; Qian J; Lv GY
    World J Gastroenterol; 2014 Dec; 20(47):17985-92. PubMed ID: 25548498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
    Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
    Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and metabolic syndrome are related to non-alcoholic fatty liver disease, but not visceral adiposity index, in severely obese patients.
    Díez-Rodríguez R; Ballesteros-Pomar MD; Calleja-Fernández A; González-De-Francisco T; González-Herráez L; Calleja-Antolín S; Cano-Rodríguez I; Olcoz-Goñi JL
    Rev Esp Enferm Dig; 2014 Dec; 106(8):522-8. PubMed ID: 25544409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of hydrogen proton magnetic resonance spectroscopy in the determination of liver triglyceride in patients with fatty liver disease and its influencing factors].
    Qu HJ; Wang L; Jin PH; Gao Q; Zhou JX; Song Y; Wang J; Jiang YM; Gong L; Chen GY; Ding JP; Shi JP
    Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):858-863. PubMed ID: 29325281
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease.
    Gelli C; Tarocchi M; Abenavoli L; Di Renzo L; Galli A; De Lorenzo A
    World J Gastroenterol; 2017 May; 23(17):3150-3162. PubMed ID: 28533672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waist circumference is associated with liver fat in black and white adolescents.
    Lee S; Kuk JL; Boesch C; Arslanian S
    Appl Physiol Nutr Metab; 2017 Aug; 42(8):829-833. PubMed ID: 28334548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A community-based study on the application of fatty liver index in screening subjects with nonalcoholic fatty liver disease.
    Chen LW; Huang PR; Chien CH; Lin CL; Chien RN
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):173-181. PubMed ID: 30981560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of liver ultrasound for the diagnosis of nonalcoholic fatty liver disease in overweight and obese patients.
    Bril F; Ortiz-Lopez C; Lomonaco R; Orsak B; Freckleton M; Chintapalli K; Hardies J; Lai S; Solano F; Tio F; Cusi K
    Liver Int; 2015 Sep; 35(9):2139-46. PubMed ID: 25847730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.